NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What is the first line treatment for Tumor Lysis Syndrome (TLS)?

Allopurinol
Rasburicase
Hydration only
Allantoin

The correct answer is: Allopurinol

Tumor Lysis Syndrome (TLS) is a serious condition that can occur when cancer cells break down quickly and release large amounts of waste products into the bloodstream. This can cause severe electrolyte imbalances and other complications. The first line treatment for TLS is Allopurinol, which is a medication commonly used to prevent high levels of uric acid in the blood. This helps to prevent uric acid crystals from forming in the kidneys, which can lead to kidney damage. Rasburicase (B) is also an effective treatment for TLS, but it is typically used in more severe cases or as a second line treatment. Hydration alone (C) is not enough to effectively manage TLS, as it does not address the underlying issue of elevated uric acid levels. Allantoin (D) is not a recommended treatment for TLS and does not have any proven benefits in managing this condition.